CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV

Reverse Transcription Recombinase Polymerase Amplification Coupled with CRISPR-Cas12a for Facile and Highly Sensitive Colorimetric SARS-CoV-2 Detection

(2021) Wei S. Zhang et al.   ANALYTICAL CHEMISTRY

An integrated biosensor platform for extraction and detection of nucleic acids

(2020) Emanuele L. Sciuto et al.   BIOTECHNOLOGY AND BIOENGINEERING

Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system

(2020) S. Wang et al.   CLINICAL MICROBIOLOGY AND INFECTION

Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2

(2020) Wanbing Liu et al.   JOURNAL OF CLINICAL MICROBIOLOGY

CRISPR–Cas12-based detection of SARS-CoV-2

(2020) James P. Broughton et al.   NATURE BIOTECHNOLOGY

Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing

(2020) Julia Joung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA

(2020) Maturada Patchsung et al.   Nature Biomedical Engineering

Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus Infection

(2020) Magda Rybicka et al.   Microorganisms

opvCRISPR: One-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection

(2020) Rui Wang et al.   BIOSENSORS & BIOELECTRONICS

CRISPR-Cas12a-Based Nucleic Acid Amplification-Free DNA Biosensor via Au Nanoparticle-Assisted Metal-Enhanced Fluorescence and Colorimetric Analysis

(2020) Jin-Ha Choi et al.   NANO LETTERS

Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis

(2020) Mingjuan Tan et al.   Lancet Gastroenterology & Hepatology

SHERLOCK: nucleic acid detection with CRISPR nucleases

(2019) Max J. Kellner et al.   Nature Protocols

Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource-limited settings by Loop-Mediated Isothermal Amplification assay

(2018) A. Akram et al.   JOURNAL OF VIRAL HEPATITIS

Field-deployable viral diagnostics using CRISPR-Cas13

(2018) Cameron Myhrvold et al.   SCIENCE

CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity

(2018) Janice S. Chen et al.   SCIENCE

CRISPR-Cas12a-assisted nucleic acid detection

(2018) Shi-Yuan Li et al.   Cell Discovery

CRISPR-Cas guides the future of genetic engineering

(2018) Gavin J. Knott et al.   SCIENCE

Programmed DNA destruction by miniature CRISPR-Cas14 enzymes

(2018) Lucas B. Harrington et al.   SCIENCE

Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers

(2017) Maria Pfefferkorn et al.   GUT

Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1

(2017) Takashi Yamano et al.   MOLECULAR CELL

Nucleic acid detection with CRISPR-Cas13a/C2c2

(2017) Jonathan S. Gootenberg et al.   SCIENCE

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

(2015) Aparna Schweitzer et al.   LANCET

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection

(2014) Yasushi Seo   WORLD JOURNAL OF GASTROENTEROLOGY

Recent advances in molecular diagnostics of hepatitis B virus

(2014) Sibnarayan Datta   WORLD JOURNAL OF GASTROENTEROLOGY

Establishment and validation of an ELISA for the quantitation of HBsAg in recombinant hepatitis B vaccines

(2010) Catia Inês Costa et al.   JOURNAL OF VIROLOGICAL METHODS

Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia

(2009) Yun-Fan Liaw   JOURNAL OF HEPATOLOGY

Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain

(2009) Rocio González et al.   TRANSFUSION